| Page 1954 | Kisaco Research
 

Wolfgang Haag

Managing Director – Brazil
Vetoquinol

Wolfgang Haag

Managing Director – Brazil
Vetoquinol

Wolfgang Haag

Managing Director – Brazil
Vetoquinol
 

Gláucia Penteado Gigli

Head of Companion Animal Business Unit
Mars Brazil

Career developed in the areas of Business Unit Manager, Marketing, Market Research and Prospect of New Products and Markets, Strategic Planning, Market Monitoring, Training and Promotion.

Result oriented leader with excellent communication skills and strong competitive & team spirit.

Gláucia Penteado Gigli

Head of Companion Animal Business Unit
Mars Brazil

Gláucia Penteado Gigli

Head of Companion Animal Business Unit
Mars Brazil

Career developed in the areas of Business Unit Manager, Marketing, Market Research and Prospect of New Products and Markets, Strategic Planning, Market Monitoring, Training and Promotion.

Result oriented leader with excellent communication skills and strong competitive & team spirit.

Successful track record including marketing/product management, sales management, strategy development and execution, business/financial analysis, sales force motivation and direction, customer relationship building, cross functional team building. Excellent organizational skills and personal dedication to meeting and exceeding established goals.

QUALIFICATIONS
- Experience in Business Unit Management, Marketing, Sales and Products - acquired by working for multinationals in the Animal Health pharmaceutical segment.

- Making of the Business Unit’s Strategic Planning, including definition of strategic and merchandising actions with regard to products, distribution channels, completion time, prices, technical and marketing actions.

- Planning and management of the Business Unit’s budget and P&L.

- Leadership and development of Brazil’s Sales team with focus on promotion, sales, management of key accounts / distribution chain and application of demand-generating tools.

- Formation and management of distribution network in Brazil and of key accounts.

- Participation in three mergers (2002, 2008, 2011).

- Research and prospection of new products, businesses, markets and opportunities, ranging from conception to launch of products.

- Launch of therapeutic and biological products into the companion animals market.

- Member of “Communication and Social Initiative Team” for 6 years, participating in the development and implementation of the company´s social projects and volunteering initiatives.


Specialties: Pharmaceutical industry; Animal Health market

 

Dr Mark Aspinall O'Dea

Retrogenix

Dr Mark Aspinall O'Dea

Retrogenix

Dr Mark Aspinall O'Dea

Retrogenix
 

Tim Saint

Senior Director Business Development
MARKEN

Tim Saint has been providing logistics and supply chain management services to the pharmaceutical industry for over 25 years. 

Firstly as Logistics Director at a leading CRO, and since 2002 with Marken, where he has developed and delivered sophisticated solutions to the ever more complex pharmaceutical and life science industry logistics requirements.

Tim Saint

Senior Director Business Development
MARKEN

Tim Saint

Senior Director Business Development
MARKEN

Tim Saint has been providing logistics and supply chain management services to the pharmaceutical industry for over 25 years. 

Firstly as Logistics Director at a leading CRO, and since 2002 with Marken, where he has developed and delivered sophisticated solutions to the ever more complex pharmaceutical and life science industry logistics requirements.

As a recognised expert in the field, Tim has for the last five years been building the Marken Cell & Gene Therapy business. He has been responsible for establishing processes and procedures which have become the industry standard for ensuring logistics compliance and patient safety.

By overcoming the logistics barriers through innovative and analytical approaches, Tim has been able to make happen what others have struggled to achieve in the very demanding environment of personalised medicine.   

 

Prof. Dr. Gisbert Schneider

Professor of Computer-Assisted Drug Design, AVP ETH Global
ETH Zurich

Prof. Dr. Gisbert Schneider

Professor of Computer-Assisted Drug Design, AVP ETH Global
ETH Zurich

Prof. Dr. Gisbert Schneider

Professor of Computer-Assisted Drug Design, AVP ETH Global
ETH Zurich